-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704A.O2.6 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Expanding Disease Targets for CAR-T Cell Therapies

Symposia: Cellular Immunotherapies: Early Phase and Investigational Therapies Program: Oral and Poster Abstracts
Type: Oral
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Room 6B (San Diego Convention Center)
Moderators:
Azra Borogovac, MD, and Sushma Bharadwaj, MD, MS,
Disclosures:
Borogovac: Takeda Pharmaceutical: Honoraria.
2:00 PM

Anand S Bhagwat, MD, PhD1,2, Leonel Torres3*, Olga Shestova, PhD4*, Maksim Shestov5*, Noelle V. Frey, MD, MS5, Elizabeth O Hexner, MD, MSTR5, Selina M Luger, MD, FRCPC6, Alison W Loren, MD7, Mary Ellen Martin, MD5, Shannon R McCurdy, MD5, Alexander Perl5, Edward A. Stadtmauer, MD8, James K. Mangan, MD9, Jennifer Brogdon, PhD10, Joseph A Fraietta, PhD11*, Wei-Ting Hwang, PhD12*, Don L. Siegel, MD, PhD2, Saad S. Kenderian, MD13, David L. Porter, MD14, Carl June, MD3 and Saar Gill, MD, PhD5

1Children's Hospital of Philadelphia, Philadelphia, PA
2University of Pennsylvania, Philadelphia, PA
3Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
4Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
6Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
7Cellular Therapy and Transplantation, Perelman Center for Advanced Medicine, Philadelphia, PA
8Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
9UCSD Moores Cancer Center, La Jolla, CA
10Novartis Institutes For Biomedical Research, Cambridge, MA
11Center for Cellular Immunotherapies, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
12Department of Biostatistics, Epidemiology, and Informatics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
13Division of Hematology, Mayo Clinic, Rochester, MN
14Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

2:15 PM

Xian Zhang, MD1,2*, Junfang Yang2,3*, Jingjing Li2,3*, Liyuan Qiu3*, Hongxing Liu Sr., MD2, Min Xiong3*, Jianqiang Li, PhD4* and Peihua Lu, MD1,5*

1Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Beijing Lu Daopei Institute of Hematology, Beijing, China
3Hebei Yanda Lu Daopei Hospital, Langfang, China
4Hebei Senlang Biotechnology Co., Ltd., Shijiazhuang, China
5Beijing Lu Daopei Institute of Hematology, Langfang, China

2:30 PM

Susan Bal, MD1, Myo Htut, MD2, Omar Nadeem, MD3, Larry D. Anderson Jr., MD, PhD4, Hakan Koçoğlu5*, Tara Gregory, MD6, Adriana C Rossi, MD, MSc7, Tom Martin8*, Daniel N. Egan, MD9, Luciano Costa, MD, PhD1, Hongxiang Hu10*, Yanping Chen10*, Shaoyi Li10*, Lisa M. Kelly10*, Naomey Sarkis10*, Safiyyah Ziyad10*, Wei-Ming Kao, MD, PhD10, Allison June Kaeding, MD10, Michael R. Burgess, MD, PhD10 and Jésus G Berdeja, MD11

1University of Alabama at Birmingham, Birmingham, AL
2City of Hope Comprehensive Cancer Center, Duarte, CA
3Dana-Farber Cancer Institute, Boston, MA
4Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, Dallas, TX
5University of Maryland, Baltimore, MD
6The Colorado Blood Cancer Institute a part of Sarah Cannon Cancer Institute at Presbyterian/St Luke's Medical Center, Denver, CO
7Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
8University of California, San Francisco, CA
9Swedish Cancer Institute, Seattle, WA
10Bristol Myers Squibb, Princeton, NJ
11Sarah Cannon Research Institute, Nashville, TN

2:45 PM

Fabian Mueller, MD1,2*, Jule Taubmann, MD3*, Simon Voelkl, PhD4,5*, Laura Bucci, MD6*, Christina Bergmann, MD3*, Michael Aigner, PhD4,5*, Artur Wilhelm, PhD3*, Tobias Rothe, PhD3*, Ioanna Minopoulou, MD3*, Johannes Knitza, MD6*, Soraya Kharboutli, MD4,7*, Silvia Spoerl, MD8*, Ingrid Vasova, MD8*, Dagmar Werner3*, Hannah Reimann, PhD4,5*, Sascha Kretschmann, PhD4,5*, Dimitrios Mougiakakos9, Gerhard Krönke, MD10*, Georg Schett, MD3* and Andreas Mackensen, MD4,5*

1Bavarian Cancer Research Center (BZKF), R/R ALL Study Group, Bavaria, Germany
2Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Bavaria, Germany
3Department of Internal Medicine 3 - Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany
4Bavarian Cancer Research Center (BZKF), Erlangen, Germany
5Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
6Department of Internal Medicine 3 - Rheumatology and Immunology; University of Erlangen, Erlangen, Germany
7Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
8Department of Internal Medicine 5 - Hematology and Oncology; University of Erlangen, Erlangen, Germany
9Department of Hematology and Oncology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
10Department of Rheumatology and Immunology, Charité University of Berlin, Berlin, Germany

3:00 PM

Elizabeth Lihua Elizabeth Budde, MD, PhD1, Marissa Morales Del Real, PhD2*, John H. Baird, MD3, Lu Chen, PhD4*, Joo Y. Song, MD5, Swetha Kambhampati, MD3, Alan Macias2*, Teresa Kim6*, Sylvia Dulan6*, Baishakhi Barva, MBBS6*, Sandrine Puverel, PhD3*, Katrin Tiemann, PhD6*, Hazel Ting-Ying Cheng, PhD7*, Stephen J. Forman, MD, FACP3 and Larry W. Kwak, MD, PhD3

1Department of Hematology and HCT, City of Hope, Duarte, CA
2T-Cell Therapeutics Research Laboratories, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
3Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
4Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
5Beckman Research Institute, City of Hope, Duarte, CA
6City of Hope National Medical Center, Duarte, CA
7PeproMene Bio. Inc, Irvine, CA

3:15 PM

Claire Roddie, MD, PhD1*, Karamjeet S. Sandhu, MD2, Eleni Tholouli, MD, PhD3*, Paul Shaughnessy, MD4*, Pere Barba, MD5, Manuel Guerreiro, MD, PhD6*, Michael R. Bishop, MD7, Jean A. Yared, MD8, Armin Ghobadi, MD9, Deborah Yallop, MD, PhD10*, Aaron C. Logan, MD, PhD11, Amer M. Beitinjaneh, MD, MS12*, Jeremy M. Pantin, MD13*, Martha Arellano14, Sridhar Chaganti, MD, PhD, FRCPath, MRCP15*, Ram Malladi, PhD16*, Tobias Menne, PhD17*, Virginia Escamilla Gómez, MD, PhD18*, Katharine Hodby, PhD19*, Krishna Gundabolu, MBBS, MS20*, Luke Mountjoy, DO21*, Kristen M. O'Dwyer, MD22, Sameem Abedin, MD23, Hassan Alkhateeb, MD24*, Bijal D. Shah, MD25, Pierre Lao-Sirieix, PhD26*, Gianfranco Pittari, MD, PhD27*, Kapil Saxena, MD28*, Yiyun Zhang, PhD28*, Wolfram Brugger, MD, PhD29, Martin A. Pule, MD26*, Jae H. Park, MD30, Daniel J. DeAngelo, MD31 and Elias Jabbour32

1University College London Cancer Institute, London, United Kingdom
2City of Hope National Medical Center, Duarte, CA
3Manchester Royal Infirmary, Manchester, United Kingdom
4Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
5Hospital Universitari Vall d’Hebron-Universitat Autónoma de Barcelona, Barcelona, Spain
6Hospital Universitari I Politècnic La Fe, Valencia, Spain
7University of Chicago, Chicago, IL
8University of Maryland Marlene and Stewart Comprehensive Cancer Center, Baltimore, MD
9Division of Oncology, Washington University School of Medicine, Saint Louis, MO
10King’s College Hospital London, London, United Kingdom
11Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California at San Francisco, San Francisco, CA
12University of Miami, Miami, FL
13Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN
14Emory University School of Medicine, Atlanta, GA
15University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
16Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
17Newcastle Upon Tyne NHS Hospitals Foundation Trust, Newcastle, United Kingdom
18Hospital Universitario Virgen del Rocío Sevilla, Seville, Spain
19University Hospital Bristol, Bristol, United Kingdom
20University of Nebraska Medical Center, Omaha, NE
21Colorado Blood Cancer Institute, Denver, CO
22University of Rochester Medical Center, Rochester, NY
23Medical College of Wisconsin, Milwaukee, WI
24Mayo Clinic, Rochester, MN
25Moffitt Cancer Center, Tampa, FL
26Autolus Therapeutics, London, United Kingdom
27Autolus Therapeutics, Basel, Switzerland
28Autolus Therapeutics, Rockville, MD
29Autolus Therapeutics, Munich, Germany
30Memorial Sloan Kettering Cancer Center, New York, NY
31Dana-Farber Cancer Institute, Boston, MA
32University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH